Evaluation of treatment response
| Complete clinical remission . | Parameter . |
|---|---|
| Hemoglobin, g/dL | >12 |
| Platelets | >150 × 109/L |
| Absolute neutrophil count | >1.5 × 109/L |
| Lymphocyte count | <4 × 109/L |
| LGL count | In the normal range |
| Complete molecular remission | For T-LGLL, disappearance of T-cell clone using polymerase chain reaction |
| Partial response | Any improvement in blood counts that do not satisfy complete remission |
| Treatment failure | No improvement within 4 months after start of treatment |
| Complete clinical remission . | Parameter . |
|---|---|
| Hemoglobin, g/dL | >12 |
| Platelets | >150 × 109/L |
| Absolute neutrophil count | >1.5 × 109/L |
| Lymphocyte count | <4 × 109/L |
| LGL count | In the normal range |
| Complete molecular remission | For T-LGLL, disappearance of T-cell clone using polymerase chain reaction |
| Partial response | Any improvement in blood counts that do not satisfy complete remission |
| Treatment failure | No improvement within 4 months after start of treatment |